Brief: Lineage Announces Issuance Of U.S. Patent Covering Proprietary Manufacturing And Differentiation Process For Retinal Pigmented Epithelial Cells
11/10/2023 13:11
Oct 11 (Reuters) - Lineage Cell Therapeutics Inc
LCTX.A :
* LINEAGE ANNOUNCES ISSUANCE OF U.S. PATENT COVERING
PROPRIETARY
MANUFACTURING AND DIFFERENTIATION PROCESS FOR RETINAL PIGMENTED
EPITHELIAL CELLS
Source text for Eikon: ID:nBw9XJ023a
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million